Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-099286
Filing Date
2022-09-12
Accepted
2022-09-12 17:00:41
Documents
1
Period of Report
2022-09-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2225655-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2225655-2_4seq1.xml 4 4095
  Complete submission text file 0001104659-22-099286.txt   5644
Mailing Address
Business Address
GOLDSTEIN DOV A MD (Reporting) CIK: 0001120478 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 221239136

Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations